Your search returned 34 results.

Results
	21.	Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression. [electronic resource] by Kuppuswamy, M Spencer, J F Doronin, K Tollefson, A E Wold, W S M Toth, K Producer: 20060301 In: Gene therapy vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy. [electronic resource] by Doronin, K Kuppuswamy, M Toth, K Tollefson, A E Krajcsi, P Krougliak, V Wold, W S Producer: 20010405 In: Journal of virology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	The E3-10.4K protein of adenovirus is an integral membrane protein that is partially cleaved between Ala22 and Ala23 and has a Ccyt orientation. [electronic resource] by Krajcsi, P Tollefson, A E Anderson, C W Stewart, A R Carlin, C R Wold, W S Producer: 19920312 In: Virology vol. 187 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. [electronic resource] by Tollefson, A E Scaria, A Hermiston, T W Ryerse, J S Wold, L J Wold, W S Producer: 19960718 In: Journal of virology vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	25.	A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2. [electronic resource] by Wilson-Rawls, J Saha, S K Krajcsi, P Tollefson, A E Gooding, L R Wold, W S Producer: 19900924 In: Virology vol. 178 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	26.	The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors. [electronic resource] by Young, B A Spencer, J F Ying, B Tollefson, A E Toth, K Wold, W S M Producer: 20140408 In: Cancer gene therapy vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	27.	The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. [electronic resource] by Gooding, L R Ranheim, T S Tollefson, A E Aquino, L Duerksen-Hughes, P Horton, T M Wold, W S Producer: 19910819 In: Journal of virology vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	28.	GP73, a novel Golgi-localized protein upregulated by viral infection. [electronic resource] by Kladney, R D Bulla, G A Guo, L Mason, A L Tollefson, A E Simon, D J Koutoubi, Z Fimmel, C J Producer: 20000720 In: Gene vol. 249 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	29.	The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. [electronic resource] by Krajcsi, P Dimitrov, T Hermiston, T W Tollefson, A E Ranheim, T S Vande Pol, S B Stephenson, A H Wold, W S Producer: 19961107 In: Journal of virology vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	30.	Adenovirus death protein (ADP) is required for lytic infection of human lymphocytes. [electronic resource] by Murali, V K Ornelles, D A Gooding, L R Wilms, H T Huang, W Tollefson, A E Wold, W S M Garnett-Benson, C Producer: 20140310 In: Journal of virology vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	31.	Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. [electronic resource] by Tollefson, A E Toth, K Doronin, K Kuppuswamy, M Doronina, O A Lichtenstein, D L Hermiston, T W Smith, C A Wold, W S Producer: 20011011 In: Journal of virology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	32.	Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. [electronic resource] by Tollefson, A E Hermiston, T W Lichtenstein, D L Colle, C F Tripp, R A Dimitrov, T Toth, K Wells, C E Doherty, P C Wold, W S Producer: 19980514 In: Nature vol. 392 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	33.	An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector. [electronic resource] by Lichtenstein, D L Spencer, J F Doronin, K Patra, D Meyer, J M Shashkova, E V Kuppuswamy, M Dhar, D Thomas, M A Tollefson, A E Zumstein, L A Wold, W S M Toth, K Producer: 20090922 In: Cancer gene therapy vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	34.	INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. [electronic resource] by Ying, B Toth, K Spencer, J F Meyer, J Tollefson, A E Patra, D Dhar, D Shashkova, E V Kuppuswamy, M Doronin, K Thomas, M A Zumstein, L A Wold, W S M Lichtenstein, D L Producer: 20090922 In: Cancer gene therapy vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)